Inhibition of vascular endothelial growth factor in the treatment of solid tumors-Reference-Cited by-同舟云学术

Inhibition of vascular endothelial growth factor in the treatment of solid tumors

Published:2002-02 Issue:1 Volume:4 Page:20-28
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Margolin Kim

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-002-0044-9.pdf

Reference138 articles.

1. Fidler IJ: Cancer biology: invasion and metastasis. In Clinical Oncology, edn 2. Edited by Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. New York: Churchill Livingstone; 2000:29–53.

2. Holash J, Maisonpierre PC, Compton D, et al.: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 284:1994–1998.

3. Pluda JM: Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. Semin Oncol 1997, 24:203–218.

4. Ferrara N, Houck K, Jakeman L, et al.: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992, 13:18–32.

5. Folkman J, Klagsburn M: Angiogenic factors. Science 1987, 235:442–447.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activated Salivary MMP-2 - A Potential Breast Cancer Marker;The Open Conference Proceedings Journal;2017-03-22

2. Reinforcing endothelial junctions prevents microvessel permeability increase and tumor cell adhesion in microvessels in vivo;Scientific Reports;2015-10-28

3. A phase I trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignancies;Cancer Chemotherapy and Pharmacology;2013-03-07

4. FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer;Oncogene;2011-08-22

5. PEI-g-PEG-RGD/Small Interference RNA Polyplex-Mediated Silencing of Vascular Endothelial Growth Factor Receptor and Its Potential as an Anti-Angiogenic Tumor Therapeutic Strategy;Oligonucleotides;2011-04